Drupal.behaviors.print = function(context) {window.print();window.close();}>
Trovagene Licenses Leukemia Marker to Quest Diagnostics
September 13, 2012
Trovagene Licenses Leukemia Marker to Quest Diagnostics
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Novartis' Genoptix Licenses Trovagene Marker for AML Services
December 20, 2012 / GenomeWeb Daily News
Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer
April 26, 2013 / GenomeWeb Daily News
LabCorp Licenses Sequella Technology for TB Assay Development
October 22, 2012 / GenomeWeb Daily News
Quest, Beth Israel, Weill Cornell Collaborate on MDx for Organ Renal Transplant Rejection
March 16, 2012 / GenomeWeb Daily News
TrovaGene Licenses SF3B1 Mutations, Plans LDT
January 3, 2012 / GenomeWeb Daily News